TickerGuard
Buy Day today: Neutral (56) Mixed market breadth · no major macro event
FHTX

Foghorn Therapeutics Inc

Healthcare · Biotechnology

3.50$ -2.8% vs. previous close Closing price · As of: Sep 25, 2026

Statements

Income Statement

All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.

Tick rows to compare them in a chart (up to 4)

Income Statement FHTX
Line item 2018 2019 2020 2021 2022 2023 2024 2025
– – – +206.7% +1,357.8% +77.6% -33.8% +36.8%
– +373.1% +3,118.9% -87.0% -99.7% +570,364.9% -97.2% +6.8%
– – – – +1,356.3% +77.8% -33.8% +22.0%
– +109.0% +30.1% +39.2% +31.5% +3.9% -13.8% -9.6%
– +39.3% +67.3% +93.2% +41.5% +5.3% -12.4% -2.9%
– +89.2% -77.2% +807.5% +33.6% +4.2% -11.8% -12.5%
– – – – – – – –
– +45.6% +81.3% +94.7% +506.9% – – –
– – – – – – – –
– +550.6% +81.3% +94.7% -100.4% – – –
– – – – – – – –
– – – – – – – –

Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?